Cerebrolysin vs Semax — Peptide Comparison

Cerebrolysin vs Semax — Peptide Comparison Cerebrolysin vs Semax — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Cerebrolysin 5–50 ml Semax 200–900 mcg Frequency Once daily Administration Intravenous (IV) injection or infusion Intranasal spray Cycle Length 8-12 weeks 4-6 weeks Onset Speed Moderate (1-2 weeks) Rapid (hours to days) Evidence Level Moderate human trials (Phase 1-2) Efficacy Stroke Recovery Alzheimer's Support Brain Injury Healing Cognitive Enhancement Neuroprotection Mental Energy Technical Data Molecular Formula Complex mixture — no single molecular formula (contains multiple peptide fragments and free amino acids derived from porcine brain proteins) Molecular Weight Bioactive peptide components are all below 10 kDa (10,000 Da); the preparation contains a spectrum of peptide sizes Half-Life Approximately 15-30 minutes (IV administration) Bioavailability ~85-100% (intramuscular injection) CAS Number Not assigned (biological mixture) C37H51N9O10S 813.9 g/mol Several minutes to hours (intranasal effects persist longer) High via intranasal route (directly reaches brain) 80714-61-0 Protocols starting 10 mL 10-20 day course, repeated every 3-6 months A gentle starting dose given as a slow IV infusion (often diluted in saline). Used in dementia and recovery programs. [6][7] standard 20-30 mL 10-21 day course, repeated in cycles The common clinical dose. Trials in vascular dementia used 20 mL daily, and stroke trials used 30 mL daily (diluted to about 100 mL saline) infused over ~30 minutes. [6][7] advanced 30-50 mL 10-21 days for stroke or severe brain injury The higher end used for acute stroke and severe traumatic brain injury, given as a diluted IV infusion under medical supervision. [7] 5-10 mL Up to 10-20 days per course For smaller doses, Cerebrolysin can be given as an intramuscular injection (no more than ~5 mL per injection site). Often used for milder cases or maintenance between IV cycles. [7] 250-500 mcg/day Once or twice daily 1-2 weeks Cognitive/nootropic practice with the 0.1% solution; downstream BDNF/NGF effects persist 12-24 h so dosing is once to twice daily [1][2]. 500-900 mcg/day Divided 2-3 times daily 3-4 weeks Mid-range nootropic practice dose; upregulates hippocampal BDNF/TrkB in animal models [1][2][3]. Applications Post-stroke neurorecovery and rehabilitation support Cerebrolysin is particularly well-suited for individuals focused on post-stroke neurorecovery and rehabilitation support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Cognitive support in Alzheimer's disease and vascular dementia Cerebrolysin is particularly well-suited for individuals focused on cognitive support in alzheimer's disease and vascular dementia. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Traumatic brain injury recovery and neuroprotection Cerebrolysin is particularly well-suited for individuals focused on traumatic brain injury recovery and neuroprotection. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Age-related cognitive decline and mild cognitive impairment Cerebrolysin is particularly well-suited for individuals focused on age-related cognitive decline and mild cognitive impairment. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Students and Knowledge Workers If your day revolves around learning, studying, or processing complex information, Semax can be a game-changer. It enhances memory consolidation and recall while improving your ability to focus for extended periods—perfect for exam prep or demanding projects. Those Seeking Mental Clarity Brain fog? Semax works by boosting BDNF—the protein that helps neurons communicate effectively. Users often report feeling like the 'mental static' clears away, leaving sharper, more efficient thinking in its place. Neuroprotection Seekers Beyond immediate cognitive benefits, Semax offers protective effects for your brain cells. It acts as an antioxidant (especially against copper toxicity) and supports neuronal health—valuable for anyone concerned about long-term brain wellness. Recovery Support (Under Medical Supervision) In Russia, Semax is approved for helping stroke patients and those with traumatic brain injuries recover cognitive function. While not FDA-approved for this use elsewhere, the research shows meaningful neuroprotective and neurorestorative properties. Safety Profile Common Injection site reactions Headache Dizziness and vertigo Nausea and gastrointestinal discomfort Agitation or restlessness Fever Uncommon Allergic reaction Serious Severe hypersensitivity reaction Nasal irritation Mild headache Increased alertness Temporary blood pressure increase Dizziness Research Status FDA Status Research compound Safety Overview Cerebrolysin is an FDA-unregulated neuroprotective agent consisting of porcine brain-derived peptides and amino acids that has been used primarily in Eastern Europe and Asia. Safety data is limited to observational clinical use and small open-label trials rather than rigorous randomized controlled trials with formal safety monitoring. As a complex mixture of undefined peptide fragments from animal sources, batch consistency and sterility cannot be guaranteed without pharmaceutical manufacturing standards. Potential allergic reactions to porcine proteins and transmissible spongiform encephalopathy (TSE) risks from animal-derived components have not been adequately ruled out. Contraindications xKnown hypersensitivity to Cerebrolysin or porcine-derived products xSevere renal impairment or renal failure xStatus epilepticus or uncontrolled epilepsy xPregnancy and breastfeeding — insufficient safety data Semax has been used clinically in Russia for over 25 years with an excellent safety profile. It's approved there for treating stroke, cognitive impairment, and optic nerve diseases. Studies consistently show minimal side effects, mostly limited to mild nasal irritation when using the spray form. Unlike stimulants, Semax doesn't appear to cause tolerance, dependence, or withdrawal symptoms even with extended use. xPregnancy or planning to become pregnant xCurrently breastfeeding xHistory of seizures or epilepsy xKnown allergy to ACTH-related peptides xUncontrolled hypertension Decision Guide Choose Cerebrolysin if... Post-stroke neurorecovery and rehabilitation support Cognitive support in Alzheimer's disease and vascular dementia Traumatic brain injury recovery and neuroprotection Age-related cognitive decline and mild cognitive impairment Choose Semax if... Cognitive enhancement Memory improvement Focus and concentration Neuroprotection